vbivaccines.com - VBIV Operating Sales Margin

VBI Vaccines, Inc. - graphic logo of issuer VBIV

Stable utilization of VBI Vaccines Inc. (VBIV) sterile production lines drives efficiency gains, which is reflected in the operational margin profile. Strong pricing power derived from the unique eVLP platform and automated, human-free biosynthesis bolster financial stability. The value of 0.00 represents the latest metric reading, demonstrating the company's current core operating profitability.

VBIV: VBI Vaccines, Inc. Operating Margin 07/04/2022 - 08/17/2024

Analytical breakdowns for VBI Vaccines Inc.

- stock quotes and analyst forecast:
Initial company analysis:VBIV, VBI Vaccines Inc
Finished products of VBI Vaccines

Operating margin measures the share of profit from core business operations before taxes and interest payments, demonstrating cost management efficiency and internal asset profitability. Analyzing this operating profitability allows for an assessment of the monetization potential of the eVLP platform for VBI Vaccines Inc. (VBIV), where an increase in this metric would confirm a successful commercial capture of the virology market through the global implementation of the PreHevbrio vaccine.